The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 09, 2019
Filed:
Oct. 20, 2015
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Idenix Pharmaceuticals Llc, Cambridge, MA (US);
Bryon L. Simmons, Hamilton, NJ (US);
Kevin R. Campos, Berkeley Heights, NJ (US);
Artis Klapars, Edison, NJ (US);
Alistair J. Stewart, Wayland, MA (US);
Benjamin A. Mayes, Boston, MA (US);
Peter E. Maligres, Fanwood, NJ (US);
Alan Hyde, Jersey City, NJ (US);
Steven Mark Silverman, Jersey City, NY (US);
Yong-li Zhong, Edison, NJ (US);
Adel M. Moussa, Burlington, MA (US);
Kenneth Baker, Syracuse, NY (US);
Kara Van Valkenburg, Syracuse, NY (US);
Bryon L. Simmons, Hamilton, NJ (US);
Kevin R. Campos, Berkeley Heights, NJ (US);
Artis Klapars, Edison, NJ (US);
Alistair J. Stewart, Wayland, MA (US);
Benjamin A. Mayes, Boston, MA (US);
Peter E. Maligres, Fanwood, NJ (US);
Alan Hyde, Jersey City, NJ (US);
Steven Mark Silverman, Jersey City, NY (US);
Yong-Li Zhong, Edison, NJ (US);
Adel M. Moussa, Burlington, MA (US);
Kenneth Baker, Syracuse, NY (US);
Kara Van Valkenburg, Syracuse, NY (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Idenix Pharmaceuticals LLC, Cambridge, MA (US);
Abstract
The present invention is directed to a process for making Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).